The European Medicines Agency (EMA) - who is currently carrying out a review into incidents of blood clots - says the vaccine's benefits continue to outweigh its risks.
Wakaaladda Daawada Yurub (EMA) - oo hadda wada dib u eegis ku saabsan dhacdooyinka xinjirowga dhiigga - ayaa sheegtay in faa'iidooyinka tallaalku ay yihiin kuwo wanaagsan marka loo eego halistooda laga filan karo.